Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > What are these DSU things VM keeps doling out?

<< Previous

Bullboard Posts

Next >>

Comment by WarrantOfficeron Jul 12, 2024 6:37pm

104 Views

Post# 36131040

RE:RE:RE:RE:RE:RE:What are these DSU things VM keeps doling out?

biggdogg - I believe the 10% equity incentive to be incredibly excessive. Although management is currently not maximizing their entitlement, in the future shareholders could realize a 10% gain in total outstanding shares per year. IMO, shareholders should be concerned.

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3